| Title: | Cognitive functioning and lifetime major depressive disorder in UK Biobank |
| Journal: | European Psychiatry |
| Published: | 21 Feb 2020 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/32189608/ |
| DOI: | https://doi.org/10.1192/j.eurpsy.2020.24 |
| URL: | ~Ehttps://www.cambridge.org/core/services/aop-cambridge-core/content/view/2D1047B1A36BCBD58061A1AB96B1CF83/S0924933820000243a.pdf/div-class-title-cognitive-functioning-and-lifetime-major-depressive-disorder-in-uk-biobank-div.pdf~ |
Publication 4537
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BACKGROUND: Cognitive impairment associated with lifetime major depressive disorder (MDD) is well-supported by meta-analytic studies, but population-based estimates remain scarce. Previous UK Biobank studies have only shown limited evidence of cognitive differences related to probable MDD. Using updated cognitive and clinical assessments in UK Biobank, this study investigated population-level differences in cognitive functioning associated with lifetime MDD.</p>
METHODS: Associations between lifetime MDD and cognition (performance on six tasks and general cognitive functioning [g-factor]) were investigated in UK Biobank (N-range 7,457-14,836, age 45-81 years, 52% female), adjusting for demographics, education, and lifestyle. Lifetime MDD classifications were based on the Composite International Diagnostic Interview. Within the lifetime MDD group, we additionally investigated relationships between cognition and (a) recurrence, (b) current symptoms, (c) severity of psychosocial impairment (while symptomatic), and (d) concurrent psychotropic medication use.</p>
RESULTS: Lifetime MDD was robustly associated with a lower g-factor (β = -0.10, PFDR = 4.7 × 10-5), with impairments in attention, processing speed, and executive functioning (β ≥ 0.06). Clinical characteristics revealed differential profiles of cognitive impairment among case individuals; those who reported severe psychosocial impairment and use of psychotropic medication performed worse on cognitive tests. Severe psychosocial impairment and reasoning showed the strongest association (β = -0.18, PFDR = 7.5 × 10-5).</p>
CONCLUSIONS: Findings describe small but robust associations between lifetime MDD and lower cognitive performance within a population-based sample. Overall effects were of modest effect size, suggesting limited clinical relevance. However, deficits within specific cognitive domains were more pronounced in relation to clinical characteristics, particularly severe psychosocial impairment.</p>
14 Keywords
- Activities of Daily Living
- Aged
- Aged, 80 and over
- Biological Specimen Banks
- Cognition
- Cognitive Dysfunction
- Cross-Sectional Studies
- Depressive Disorder, Major
- Executive Function
- Female
- Humans
- Male
- Middle Aged
- United Kingdom
8 Authors
- Laura de Nooij
- Mathew A. Harris
- Mark J. Adams
- Toni-Kim Clarke
- Xueyi Shen
- Simon R. Cox
- Andrew M. McIntosh
- Heather C. Whalley
Enabling scientific discoveries that improve human health